We are live on ! Find out more
MURA

Mural Oncology
MURA

Delisted

MURA was delisted on the 4th of December, 2025.

Back to rankings

101 hedge funds and large institutions have $59.9M invested in Mural Oncology in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 51 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8.27% less ownership

Funds ownership: 80.7% → 72.43% (-8.3%)

18% less funds holding

Funds holding: 123 → 101 (-22)

25% less capital invested

Capital invested by funds: $79.7M → $59.9M (-$19.8M)

58% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 38

73% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 51

Holders
101
Holders Change
-22
Holders Change %
-17.89%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
16
Increased
14
Reduced
51
Closed
38
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Solas Capital Management
Connecticut
+$3.64M
2
Verition Fund Management
Verition Fund Management
Connecticut
+$3.08M
3
BBA
Baker Bros. Advisors
New York
+$1.08M
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.05M
5
SGL
Sonic GP LLC
Hawaii
+$811K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$2.76M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$2.12M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$1.67M
4
Pictet Asset Management
Pictet Asset Management
Switzerland
-$1.67M
5
Artisan Partners
Artisan Partners
Wisconsin
-$1.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
AWM
76
Avior Wealth Management
Nebraska
$1.89K +$1.87K +386 New
Group One Trading
77
Group One Trading
Illinois
$631 +$29 +6 +5%
EWA
78
EverSource Wealth Advisors
Alabama
$566 -$714 -147 -49%
Credit Agricole
79
Credit Agricole
France
$536 – – –
UB
80
UMB Bank
Missouri
$489 – – –
Northwestern Mutual Wealth Management
81
Northwestern Mutual Wealth Management
Wisconsin
$333 – – –
QC
82
Quent Capital
New York
$269 +$267 +55 New
WT
83
Whittier Trust
California
$200 – – –
US Bancorp
84
US Bancorp
Minnesota
$181 -$505 -104 -74%
DCM
85
Davis Capital Management
Florida
$97 – – –
SPIA
86
Steward Partners Investment Advisory
New York
$73 – – –
NA
87
NewEdge Advisors
Louisiana
$48 +$24 +5 +100%
CTC
88
Central Trust Company
Missouri
$45 – – –
CIBC Private Wealth Group
89
CIBC Private Wealth Group
Georgia
$34 +$34 +7 New
FIA
90
FNY Investment Advisers
New York
$31 – – –
BIA
91
Bell Investment Advisors
California
$25 – – –
S
92
SignatureFD
Georgia
$5 -$359 -74 -99%
LC
93
Lindbrook Capital
California
$5 -$92 -19 -95%
FFA
94
Farther Finance Advisors
California
$5 -$5 -1 -50%
BWL
95
Bogart Wealth LLC
Virginia
$5 – – –
TCM
96
TD Capital Management
Tennessee
$5 – – –
VCM
97
Versant Capital Management
Arizona
$5 +$5 +1 New
CFGS
98
Concourse Financial Group Securities
Alabama
$4 – – –
Pictet Asset Management
99
Pictet Asset Management
Switzerland
– -$1.67M -281,955 Closed
Artisan Partners
100
Artisan Partners
Wisconsin
– -$1.1M -185,432 Closed
2 3
4
5 6

MURA Hedge Fund Activity: Q1 2024 in Review

101 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q1 2024, worth a combined $59.9M — down 25% from $79.7M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of MURA and 16 opened new positions — a net loss of 22 holders — while 51 trimmed existing stakes and 14 added.

The largest buyer was Solas Capital Management, opening a new position worth an estimated $3.64M. The largest seller was Vanguard Group, cutting an estimated $2.76M.

  • 101 institutional investors held Mural Oncology (MURA) as of Q1 2024, down from 123 in Q4 2023.
  • Funds reported $59.9M of Mural Oncology stock for Q1 2024, down 25% quarter-over-quarter.
  • 16 funds opened new Mural Oncology positions in Q1 2024 and 38 closed out, a net change of -22 holders.
  • The largest Mural Oncology buyer in Q1 2024 was Solas Capital Management, an estimated $3.64M added.
  • The largest Mural Oncology seller in Q1 2024 was Vanguard Group, an estimated $2.76M sold.

Based on aggregated 13F filings for Q1 2024.